Given the strong metabolic effects of IGF1 and the established links between its signaling components in conditions like obesity and diabetes, disrupted IGF1 signaling may also contribute to the development of obesity-related comorbidities (76). This evidence concerns the gene IGF1 and diabetes mellitus.